Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

UniPR505

Copy Product Info
😃Good
Catalog No. T73368Cas No. 2938227-14-4

UniPR505 is a potent EphA2 antagonist (IC50: 0.95 µM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.

UniPR505

UniPR505

Copy Product Info
😃Good
Purity: 99.98%
Catalog No. T73368Cas No. 2938227-14-4
UniPR505 is a potent EphA2 antagonist (IC50: 0.95 µM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$518In StockIn Stock
5 mg$1,170In StockIn Stock
25 mg$1,920-In Stock
50 mg$2,380-In Stock
100 mg$3,100-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.98%
ee:100%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

UniPR505 AI Summary
UniPR505 exhibits bioactivities associated with Eph receptors and their ligands. It functions as an antagonist at EphA2 receptors in human PC3 cells and competitively inhibits ephrin-A1 binding to EphA2. Furthermore, it displaces ephrin ligands from a variety of Eph receptors, including EphA3 and EphA4, among others. In addition, UniPR505 demonstrates antiangiogenic activity in HUVEC by reducing the formation of vascular structures such as polygons. The compound shows varying levels of potency across different assays, with IC50 values ranging from 950.0 nM to over 30,000.0 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
UniPR505 is a potent EphA2 antagonist (IC50: 0.95 µM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.
Targets&IC50
EphB3:11 µM, EphB2:14 µM, EphA4:6.4 µM, EphA6:18 µM, EphA3:4.5 µM, EphA8:7.7 µM, EphA2:0.95 µM, EphA5:4.4 µM
Chemical Properties
Molecular Weight647.89
FormulaC39H57N3O5
Cas No.2938227-14-4
SmilesC[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@](CC3)(C[C@H](OC(NCC)=O)CC4)[H])(CC1)[H])[H])(CC[C@@]2([C@@H](CCC(N[C@@H](CC=5C=6C(NC5)=CC=CC6)CC(O)=O)=O)C)[H])[H]
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy UniPR505 | purchase UniPR505 | UniPR505 cost | order UniPR505 | UniPR505 chemical structure | UniPR505 formula | UniPR505 molecular weight